StockData
NewAmsterdam Pharma Co N.V. logo

NewAmsterdam Pharma Co N.V. (NAMS) stock

NAMSNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as NAMSW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$19.39−0.07 (-0.36%)

Close on Nov 17, 2026Market cap $2.32BP/E –Yield –

NewAmsterdam Pharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for NewAmsterdam Pharma

NewAmsterdam Pharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More NewAmsterdam Pharma figures

See a number that looks wrong?